糖尿病治療の世界市場レポート 2025年

糖尿病治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.9％で412億1,000万米ドルに成長します。予測期間中の発展は、糖尿病有病率の増加、高齢者人口の拡大、糖尿病管理に対する意識の高まり、発展途上地域におけるヘルスケアアクセスの改善によって牽引されると予想されます。予測期間中に予想される主な動向には、糖尿病モニタリングの技術的発展、糖尿病治療における人工知能（AI）の統合、インスリン送達システムの改善、スマートインスリン装置の開発などが含まれます。

肥満の有病率の上昇は、今後数年間の糖尿病治療市場の拡大を促進すると予測されます。肥満率とは、母集団の中で肥満度を示す体格指数（BMI）が30以上の人の割合を指します。肥満の増加は、座りがちなライフスタイルへの依存の増加や、栄養価の低い加工度の高い高カロリー食品の消費が広まり、カロリー摂取量と運動量のバランスが崩れていることが主な原因です。糖尿病治療は、より良い生活習慣を促進し、血糖調節を強化し、インスリン療法や持続血糖モニタリング（CGM）技術などの高度な治療オプションを通じて体重管理をサポートすることにより、肥満に関連する健康課題に対処する上で不可欠です。例えば、2024年3月、スイスに本部を置く政府間機関である世界保健機関（WHO）は、2022年には3億9,000万人の成人が低体重であり、25億人が肥満と分類される8億9,000万人を含む過体重であると報告しました。その結果、肥満レベルの増加が糖尿病治療市場の需要を押し上げています。

糖尿病治療業界の主要企業は、自動インスリンデリバリー（AID）システムなどの新しい技術で革新を進めており、持続的血糖値モニタリング装置とインスリンポンプをシームレスに統合し、リアルタイムのインスリン調整を行うことで、血糖コントロールを強化しています。AIDシステムは、CGMとインスリンポンプを組み合わせ、現在の血糖値に基づいてインスリンレベルを自動的に管理し、患者がより安定した血糖コントロールを維持できるようにします。例えば、2024年2月、糖尿病治療に特化した米国の医療機器会社Tandem Diabetes Care Inc.は、超小型で耐久性のある自動インスリン送達システムTandem Mobiを発売しました。この目立たないチューブ型インスリンポンプは、スマートフォンのアプリで完全に操作できるため、従来のコントローラーが不要となります。この装置は防水、充電式で、DexcomのCGMシステムと統合し、Tandemが確立したControl-IQ技術を利用してインスリン投与を自動化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の糖尿病治療のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の糖尿病治療市場：成長率分析
• 世界の糖尿病治療市場の実績：規模と成長、2019～2024年
• 世界の糖尿病治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の糖尿病治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の糖尿病治療市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血糖値モニタリング装置
• インスリンポンプ
• その他
• 世界の糖尿病治療市場：糖尿病タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 2型糖尿病
• 1型糖尿病
• その他
• 世界の糖尿病治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院・診療所
• 在宅ケア設定
• 外来診療環境
• その他
• 世界の糖尿病治療市場：血糖値モニタリング装置のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 血糖値モニタリング（BGM）
• 持続血糖モニタリング（CGM）
• フラッシュ血糖モニタリング（FGM）
• 世界の糖尿病治療市場：インスリンポンプのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• パッチポンプ
• テザーポンプ
• 埋め込み型インスリンポンプ

第7章 地域別・国別分析

• 世界の糖尿病治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の糖尿病治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 糖尿病治療市場：競合情勢
• 糖尿病治療市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novo Nordisk A/S
• Boehringer Ingelheim Pharmaceuticals Inc.
• Terumo Corporation
• Dexcom Inc.
• Dr. Reddy's Laboratories Limited
• SD Biosensor Inc.
• Insulet Corporation
• Tandem Diabetes Care Inc.
• LifeScan Inc.
• Ypsomed AG
• Ascensia Diabetes Care Holdings AG
• B. Braun Melsungen AG
• Bionime Corporation
• Arkray Inc.
• ACON Laboratories Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 糖尿病治療市場2029年：新たな機会を提供する国
• 糖尿病治療市場2029年：新たな機会を提供するセグメント
• 糖尿病治療市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Diabetes care refers to the comprehensive management and treatment of diabetes mellitus, a chronic condition marked by elevated blood sugar levels. It includes a variety of medical, lifestyle, and technological interventions aimed at keeping blood glucose within a target range and preventing complications.

The primary product types in diabetes care include glucose monitoring devices, insulin pumps, and other related products. Glucose monitoring devices are medical tools designed to measure and track blood glucose levels, primarily for individuals with diabetes. The different types of diabetes include type 1 diabetes, type 2 diabetes, and other forms, with these products being used by various end users, including hospitals and clinics, home care settings, ambulatory care centers, and others.

The diabetes care market research report is one of a series of new reports from The Business Research Company that provides diabetes care market statistics, including the diabetes care industry's global market size, regional shares, competitors with the diabetes care market share, detailed diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care market. This diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diabetes care market size has grown strongly in recent years. It will grow from $26.79 billion in 2024 to $29.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth during the historic period can be attributed to rising obesity rates, increased demand for continuous monitoring devices, growing investment in diabetes research and development, and a rising demand for personalized diabetes care.

The diabetes care market size is expected to see strong growth in the next few years. It will grow to $41.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. Growth during the forecast period is expected to be driven by the increasing prevalence of diabetes, an expanding geriatric population, heightened awareness of diabetes management, and improved healthcare access in developing regions. Key trends anticipated in the forecast period include technological advancements in diabetes monitoring, the integration of artificial intelligence (AI) in diabetes care, improvements in insulin delivery systems, and the development of smart insulin devices.

The rising prevalence of obesity is anticipated to drive the expansion of the diabetes care market in the coming years. Obesity rates refer to the proportion of individuals within a population who have a body mass index (BMI) of 30 or above, indicating obesity. The growth in obesity is largely due to increased dependence on sedentary lifestyles and the widespread consumption of highly processed, calorie-dense foods that offer minimal nutritional value, leading to an imbalance between caloric intake and physical activity. Diabetes care is essential in addressing obesity-related health challenges by promoting better lifestyle habits, enhancing glucose regulation, and supporting weight management through advanced treatment options like insulin therapy and continuous glucose monitoring (CGM) technologies. For instance, in March 2024, the World Health Organization, an intergovernmental body based in Switzerland, reported that in 2022, 390 million adults were underweight, while 2.5 billion were overweight, including 890 million classified as obese. As a result, increasing obesity levels are fueling demand within the diabetes care market.

Leading companies in the diabetes care industry are innovating with new technologies, such as automated insulin delivery (AID) systems, to enhance glucose control by seamlessly integrating continuous glucose monitoring devices with insulin pumps for real-time insulin adjustments. AID systems combine CGMs with insulin pumps to automatically manage insulin levels based on current glucose readings, helping patients maintain more consistent blood sugar control. For example, in February 2024, Tandem Diabetes Care Inc., a U.S.-based medical device company focused on diabetes treatment, launched the Tandem Mobi-an ultra-compact, durable automated insulin delivery system. This discreet, tubed insulin pump can be fully operated via a smartphone app, eliminating the need for a traditional controller. The device is waterproof, rechargeable, and integrates with Dexcom's CGM system, utilizing Tandem's established Control-IQ technology to automate insulin dosing.

In January 2023, Tandem Diabetes Care Inc. acquired AMF Medical SA for an undisclosed amount. This acquisition is aimed at accelerating the development and commercialization of advanced patch pump technology, broadening Tandem's diabetes care offerings, and reaching a wider patient base. AMF Medical SA is a Switzerland-based company specializing in innovative insulin delivery solutions for diabetes management.

Major players in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy's Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.

North America was the largest region in the diabetes care market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diabetes care report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes care market consists of revenues earned by entities by providing services such as insulin therapy and medication management, nutrition and diet planning, lifestyle modification support, and telemedicine and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes care market also consists of sales of products including dietary and nutritional products, medication delivery devices, and digital and software solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetes care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Glucose Monitoring Devices; Insulin Pumps; Other Product Types
• 2) By Diabetes Type: Type 2 Diabetes; Type 1 Diabetes; Other Diabetes Type
• 3) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Care Settings; Other End Users

Subsegments

• 1) By Glucose Monitoring Devices: Blood glucose monitoring (BGM); Continuous glucose monitoring (CGM); Flash glucose monitoring (FGM)
• 2) By Insulin Pumps: Patch pump; Tethered pump; Implanted insulin pump
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Sanofi S.A.; Abbott Laboratories; Medtronic plc; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diabetes Care Market Characteristics

3. Diabetes Care Market Trends And Strategies

4. Diabetes Care Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diabetes Care Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diabetes Care PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diabetes Care Market Growth Rate Analysis
• 5.4. Global Diabetes Care Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diabetes Care Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diabetes Care Total Addressable Market (TAM)

6. Diabetes Care Market Segmentation

• 6.1. Global Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucose Monitoring Devices
• Insulin Pumps
• Other Product Types
• 6.2. Global Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type 2 Diabetes
• Type 1 Diabetes
• Other Diabetes Type
• 6.3. Global Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Homecare Settings
• Ambultaory Care Settings
• Other End Users
• 6.4. Global Diabetes Care Market, Sub-Segmentation Of Glucose Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood glucose monitoring (BGM)
• Continuous glucose monitoring (CGM)
• Flash glucose monitoring (FGM)
• 6.5. Global Diabetes Care Market, Sub-Segmentation Of By Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patch pump
• Tethered pump
• Implanted insulin pump

7. Diabetes Care Market Regional And Country Analysis

• 7.1. Global Diabetes Care Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diabetes Care Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetes Care Market

• 8.1. Asia-Pacific Diabetes Care Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetes Care Market

• 9.1. China Diabetes Care Market Overview
• 9.2. China Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetes Care Market

• 10.1. India Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetes Care Market

• 11.1. Japan Diabetes Care Market Overview
• 11.2. Japan Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetes Care Market

• 12.1. Australia Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetes Care Market

• 13.1. Indonesia Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetes Care Market

• 14.1. South Korea Diabetes Care Market Overview
• 14.2. South Korea Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetes Care Market

• 15.1. Western Europe Diabetes Care Market Overview
• 15.2. Western Europe Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetes Care Market

• 16.1. UK Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetes Care Market

• 17.1. Germany Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetes Care Market

• 18.1. France Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetes Care Market

• 19.1. Italy Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetes Care Market

• 20.1. Spain Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetes Care Market

• 21.1. Eastern Europe Diabetes Care Market Overview
• 21.2. Eastern Europe Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetes Care Market

• 22.1. Russia Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetes Care Market

• 23.1. North America Diabetes Care Market Overview
• 23.2. North America Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetes Care Market

• 24.1. USA Diabetes Care Market Overview
• 24.2. USA Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetes Care Market

• 25.1. Canada Diabetes Care Market Overview
• 25.2. Canada Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetes Care Market

• 26.1. South America Diabetes Care Market Overview
• 26.2. South America Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetes Care Market

• 27.1. Brazil Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetes Care Market

• 28.1. Middle East Diabetes Care Market Overview
• 28.2. Middle East Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetes Care Market

• 29.1. Africa Diabetes Care Market Overview
• 29.2. Africa Diabetes Care Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diabetes Care Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diabetes Care Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetes Care Market Competitive Landscape And Company Profiles

• 30.1. Diabetes Care Market Competitive Landscape
• 30.2. Diabetes Care Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Diabetes Care Market Other Major And Innovative Companies

• 31.1. Novo Nordisk A/S
• 31.2. Boehringer Ingelheim Pharmaceuticals Inc.
• 31.3. Terumo Corporation
• 31.4. Dexcom Inc.
• 31.5. Dr. Reddy's Laboratories Limited
• 31.6. SD Biosensor Inc.
• 31.7. Insulet Corporation
• 31.8. Tandem Diabetes Care Inc.
• 31.9. LifeScan Inc.
• 31.10. Ypsomed AG
• 31.11. Ascensia Diabetes Care Holdings AG
• 31.12. B. Braun Melsungen AG
• 31.13. Bionime Corporation
• 31.14. Arkray Inc.
• 31.15. ACON Laboratories Inc.

32. Global Diabetes Care Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Care Market

34. Recent Developments In The Diabetes Care Market

35. Diabetes Care Market High Potential Countries, Segments and Strategies

• 35.1 Diabetes Care Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diabetes Care Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diabetes Care Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer